Home/Filings/4/0001136261-22-000249
4//SEC Filing

O'Connor Daniel J. 4

Accession 0001136261-22-000249

CIK 0001017491other

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 4:29 PM ET

Size

11.8 KB

Accession

0001136261-22-000249

Insider Transaction Report

Form 4
Period: 2022-06-01
Transactions
  • Purchase

    Common Stock

    2022-06-01$0.61/sh+16,000$9,78916,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average purchase price. These shares were acquired in multiple open market transactions at prices ranging from $0.6054 per share to $0.6127 per share, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price.

Issuer

SEELOS THERAPEUTICS, INC.

CIK 0001017491

Entity typeother

Related Parties

1
  • filerCIK 0001376847

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:29 PM ET
Size
11.8 KB